(1) Fernando Alfageme, MD – Department of Dermatology, Hospital Puerta del Hierro, Madrid, Spain
(2) Nicolas Amoretti, MD – Department of Radiology, University Hospital, Nice, France
(3) Jelle Barentz, MD – Department of Radiology, UMC St. Radboud, Nijmegen, Netherlands
(4) Marcio Bouer, MD – Department of Radiology, Affiliation Hospital das Clínicas da Faculdade de Medicina de São Paulo, Brazil
(5) Orlando Catalano, MD – Department of Radiology, National Cancer Institute Fondazione Pascale, Naples, Italy
Click HERE for complete list of Associations
(6) Francois Cornud, MD – Department of Uro-Radiology, Cochin Hospital, Paris
(7) Jean-Michel Correas, MD – Department of Radiology, Hopital Necker, Paris
(8) Diana Gaitini, MD – Department of Medical Imaging, Rambam Health Care Centre, Haifa, Israel
(9) Claudia Gonzalez, MD – Instituto de Diagnostico Medico Bogota, Columbia
(10) Federico Guercini, MD Department of Urology, La Sapienza, Rome, Italy
(11) David Khayat, MD – Department of Oncology, Hopital Pitie-Salpetriere, Paris
(12) Anitha Mandava, MD – Department of Radiodiagnosis, Central Hospital, South Central Railway, Telangana, India.
(13) Antonio Martorelli, MD – Department of Dermatology, Hospital de Manises, Valencia, Spain
(14) Sean O’Connor, MD, FRANZR
Tabar Breast Centre Coastal Medical Imaging, Brisbane, Australia
(15) Thomas Rau, MD – Paracelsus Clinic, Lustmuhle, Switzerland
(16) Mariella Scotto, MD – Department of Radiology, Università degli studi di Napoli, Naples, Italy
(17) Ximena Wortsman, MD – Department of Radiology and Department of Dermatology, Institute for Diagnostic
Imaging and Research of the Skin and Soft Tissues University of Chile, Santiago, Chile
(18) Kian Zarch, MD – Department of Dermatology, Roskilde Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
2017 DEMUS GROUP teaching presentation on skin cancer imaging at the world conference Americal Institute of Ultrasound Medicine- Orlando, Fla. March, 2017
Diagnosing Breast Cancer
The current standard in screening for breast cancer is mammography. However, this imaging tool misses some breast tumors, especially in women with dense breasts. Published data suggests that sonography can play an important role in detecting tumors that mammography misses. In fact, over 94% of cancers seen only on ultrasound were invasive tumors with average size of 10 mm, and in the studies where staging was detailed, 91% were node negative, meaning it had not spread and complete cure was possible due to early detection. (MORE)
BARD CANCER DIAGNOSTICS is founded on the commitment to explore and implement the latest diagnostic technologies as a means of building the proper treatment strategy of many types of cancers. We also specialize in the PREVENTION solutions for our patients who strive to maintain a health-conscious lifestyle as well as those who are at increased risk of certain diseases by confirming that their efforts to prevent disease are working.
BARD CANCER DIAGNOSTICS
121 E. 60th St. Suite #6A New York, NY 10022
212.355.7017
Info@bardcancercenter.com